260 related articles for article (PubMed ID: 21190914)
1. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
Khan NW; Hassan F; Naqvi BS; Hasan SM
Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914
[TBL] [Abstract][Full Text] [Related]
2. Recent status of bacterial sensitivities to various antibiotics.
Fearn J; Ahmed SI
J Pak Med Assoc; 1976 Nov; 26(11):220-3. PubMed ID: 829148
[No Abstract] [Full Text] [Related]
3. Comparative study on resistant pattern of clinical isolates against levofloxacin and cefepime.
Nasiri MI; Naqvi SB; Zaidi AA; Saeed R; Raza G
Pak J Pharm Sci; 2013 Mar; 26(2):415-9. PubMed ID: 23455216
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
Skar AG; Midtvedt T; Dahl O
NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis.
Ruzaimi MY; Shahril Y; Masbah O; Salasawati H
Med J Malaysia; 2006 Feb; 61 Suppl A():21-6. PubMed ID: 17042224
[TBL] [Abstract][Full Text] [Related]
6. In-vitro activity of three brands of ceftriaxone against different clinical isolates.
Thapa B; Mahat K
JNMA J Nepal Med Assoc; 2010; 49(179):225-7. PubMed ID: 22049828
[TBL] [Abstract][Full Text] [Related]
7. The resistance to antibiotics of strains of Streptococcus viridans, Streptococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Proteus and Klebsiella isolated in Poland.
Jeljaszewicz J; Hawiger J
Bull World Health Organ; 1966; 35(2):243-6. PubMed ID: 5332528
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial resistance: patterns and trends in the National University Hospital, Singapore (1989-1991).
Kumarasinghe G; Liew HY; Chow C
Malays J Pathol; 1992 Dec; 14(2):95-103. PubMed ID: 1304631
[TBL] [Abstract][Full Text] [Related]
9. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
10. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Senses Z; Baysallar M; Gür D; Doğanci L
Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic sensitivity of bacteria isolated in the years 1966-1968.
Morrski M; Tkaczowa A; Wieczorek J
Arch Immunol Ther Exp (Warsz); 1970; 18(3):390-9. PubMed ID: 4923034
[No Abstract] [Full Text] [Related]
12. [Susceptibility to antimicrobial agents of 2,060 strains of different bacteria isolated in infectious processes in children].
Filloy L; Borjas E; Sierra A
Bol Med Hosp Infant Mex; 1981; 38(1):13-21. PubMed ID: 7025858
[TBL] [Abstract][Full Text] [Related]
13. [Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study].
García de Lomas J; Gimeno C; Díez J; Bermejo M; Navarro D; García-Ponte L
Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):24-8. PubMed ID: 10069109
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility pattern of bacterial isolates from post-operative wound infections.
Arya M; Arya PK; Biswas D; Prasad R
Indian J Pathol Microbiol; 2005 Apr; 48(2):266-9. PubMed ID: 16758692
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia.
Gebre-Sealsssie S
Ethiop Med J; 2007 Oct; 45(4):363-70. PubMed ID: 18326346
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
Wagenvoort JH; Brus-Weijer L; Michel MF
Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activities of commonly available quinolones and other antibiotics on bacterial isolates in Ibadan, Nigeria.
Oni AA; Bakare RA; Arowojolu AO; Kehinde Toki RA; Fasina NA
Afr J Med Med Sci; 2001; 30(1-2):35-7. PubMed ID: 14510147
[TBL] [Abstract][Full Text] [Related]
18. In-vitro anti-microbial susceptibility of clinical isolates of pathogenic bacteria to ten antibiotics including phosphomycin.
Eke PI; Rotimi VO
Afr J Med Med Sci; 1987 Mar; 16(1):1-8. PubMed ID: 3037870
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics].
Fazli SA; Aksebzeci T
Mikrobiyol Bul; 1989 Oct; 23(4):356-60. PubMed ID: 2488944
[TBL] [Abstract][Full Text] [Related]
20. Straightforward representation of antimicrobial chemotherapeutics susceptibility profiles in a private tertiary care hospital.
Arya SC; Agarwal N; Agarwal S
J Infect; 2005 Nov; 51(4):333-5. PubMed ID: 15904968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
